Patient |
Noorwid-Hamilton Classification scale |
Age |
Treatment prior to study |
Platelets (peripheral blood) |
Disease-onset (year-old) |
Ethnic group |
1 |
V |
31 |
NO |
200 G/l |
17 |
European |
3 |
IIv |
20 |
NO |
259 G/l |
17 |
European |
4 |
IIv |
24 |
NO |
233 G/l |
20 |
European |
5 |
Female pattern |
23 |
NO |
231 G/l |
17 |
Asian |
6 |
III Vertex |
33 |
NO |
210 G/l |
28 |
European |
7 |
VI |
59 |
NO |
190 G/l |
40 |
European |
8 |
IV |
43 |
Minoxidil |
223 G/l |
30 |
European |
9 |
Female pattern |
28 |
NO |
240 G/l |
25 |
European |
11 |
IV |
58 |
NO |
220 G/l |
40 |
European |
12 |
IV |
25 |
Minoxidil+Finasteride |
220 G/l |
22 |
European |
13 |
Female pattern |
36 |
NO |
169 G/l |
32 |
Arabian |
14 |
III |
31 |
NO |
253 G/l |
28 |
Pakistani |
15 |
III |
36 |
Minoxidil |
190 G/l |
32 |
European |
17 |
III |
28 |
Minoxidil |
211 G/l |
23 |
European |
2 |
III |
25 |
Finasteride |
250 G/l |
22 |
European |
10 |
III |
24 |
NO |
219 G/l |
22 |
African |
16 |
Female pattern |
32 |
NO |
311 G/l |
29 |
Asian |
|